Cargando…
Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2
Responding quickly to emerging respiratory viruses, such as SARS-CoV-2 the causative agent of coronavirus disease 2019 (COVID-19) pandemic, is essential to stop uncontrolled spread of these pathogens and mitigate their socio-economic impact globally. This can be achieved through drug repurposing, wh...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552695/ https://www.ncbi.nlm.nih.gov/pubmed/34718070 http://dx.doi.org/10.1016/j.pharmthera.2021.108027 |